Burgess Rawson is pleased to offer to market ‘Healius Pathology’ located at 34-36 Bridge Street, Bendigo VIC, for sale via Auction Investment Portfolio 165.

The property has the following key investment highlights:

+ Five (5) year net lease to ‘Healius Pathology’ to 2027.
+ Healius Ltd (ASX:HLS): Market cap ($1.05B) and one of Australia’s largest diagnostic and day hospital providers, servicing more than 15 million patients annually. 1
+ Fixed 3% annual rent increases, ensuring compounding rental growth.
+ Key collection and pathology testing centre for the greater Bendigo Region with Dorevitch being on site for over 26 years.
+ Attractive net lease with tenant paying all usual outgoings.
+ Well-maintained 419sqm* pathology laboratory with rear laneway access and on-site car parking spaces for specialised collection vehicles.
+ Strategic 789sqm* main road site adjoining complimentary Dorevitch Pathology clinical laboratory and service centre, plus exposure to 17,000+ passing vehicles daily.
+ Situated amongst key medical precinct – 300 metres from the $1.1 billion Bendigo Health, employing more than 5,000 staff, treating more than 49,000 inpatients and complemented by an integrated cancer centre. 2
+ Convenient central location amongst Bendigo CBD, 675 metres from Myer, 720 metres from Officeworks, 800 metres from Coles, and within close proximity from the Woolworths and Big W-anchored Bendigo Marketplace.
+ Bendigo: Booming residential growth location with a 37% increase in median house prices since June 2020.3
+ City of Greater Bendigo: Victoria’s largest inland city with population forecast to grow to over 155,000 by 20362 and currently generates $18.6 billion in annual economic output with an estimated 55,242 jobs in the area.4
+ Potential 50% stamp duty savings.
+ Net Income: $108,813* pa + GST


For Sale by Investment Portfolio Auction
10:30am AEDT Wednesday 6 December 2023
Crown Casino, Melbourne

*Approx.
1 Healius Pathology
2 Bendigo Health
3 realestate.com.au
4 ForecastID